文献速递角膜与眼表疾病

京尼平对犬感染性溃疡性角膜炎常见病原体的体外抗菌作用:一项犬初步研究

The In Vitro Antibacterial Effects of Genipin Against Pathogens Commonly Associated With Infected Ulcerative Keratitis: A Canine Preliminary Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

结果显示京尼平对包括MRSP在内的受试菌株均有抗菌活性,对葡萄球菌呈浓度依赖性杀菌,但铜绿假单胞菌在测试时间与浓度内未测得抗菌效果。

要点

  • 京尼平对受试犬眼部分离菌(含MRSP)显示有前景的体外抗菌活性。
  • 对葡萄球菌的杀菌作用呈浓度依赖性,高浓度下可快速杀菌。
  • 铜绿假单胞菌在测试时间与浓度内对京尼平短期作用不敏感。

核心结论

  • 京尼平对全部受试犬眼部分离株(包括MRSP)表现出有前景的抗菌活性,对葡萄球菌呈浓度依赖性杀菌,铜绿假单胞菌对短期作用较不敏感。

研究设计与样本

  • 检测最低抑菌浓度(MIC)与最低杀菌浓度(MBC),并在此基础上进行时间-杀菌试验,于0、10、30、60和120分钟进行活菌计数。

主要发现

  • 所有病原体的MIC值均因孔内内容物变蓝而无法测定。
  • MBC值范围为:MRSP 0.1%,假中间葡萄球菌和铜绿假单胞菌0.075%–0.125%,犬链球菌0.25%–0.5%。
  • 时间-杀菌分析显示,京尼平在1×MBC下120分钟对葡萄球菌呈平均抑菌作用,在2.5×MBC下120分钟和5×MBC下60分钟呈平均杀菌作用。
  • 在测试时间范围和京尼平浓度内,铜绿假单胞菌未测得抗菌效果。

关键数值与推荐

  • MBC:MRSP为0.1%,假中间葡萄球菌与铜绿假单胞菌为0.075%–0.125%,犬链球菌为0.25%–0.5%。
  • 时间-杀菌:葡萄球菌在1×MBC下120分钟为平均抑菌,2.5×MBC下120分钟和5×MBC下60分钟为平均杀菌。

临床怎么用

  • 京尼平对犬感染性溃疡性角膜炎常见葡萄球菌(含MRSP)具体外抗菌活性,提示其作为新型抗菌治疗剂的潜在价值。
  • 铜绿假单胞菌在短期测试中不敏感,临床应用于铜绿假单胞菌相关角膜炎时需谨慎评估。

局限性

  • 本研究为犬来源菌株的体外初步研究,样本量有限。
  • 所有病原体的MIC值因孔内内容物变蓝而无法测定。
  • 铜绿假单胞菌仅在测试时间范围与浓度内评估,未测得抗菌效果。
  • 京尼平的完整抗菌潜力与临床性能仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate genipin as a novel antimicrobial therapeutic agent with established crosslinking abilities by investigating its antibacterial activity against canine ocular pathogens and exploring its pharmacodynamic profile. METHODS: Nineteen bacterial strains were selected from frozen stock, including ten Staphylococcus pseudintermedius (five of which were methicillin-resistant [MRSP]), five Pseudomonas aeruginosa, and four Streptococcus canis. All strains were isolated from dogs with corneal stromal ulcerations. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were examined; subsequently, time-kill assays were performed. Viability counts were performed at 0, 10, 30, 60, and 120 minutes. RESULTS: Blue discoloration of the contents in the wells impeded the determination of the MIC values for all pathogens. MBC values ranged from 0.1% for MRSP, 0.075%-0.125% for S. pseudintermedius and P. aeruginosa, and 0.25%-0.5% for S. canis. Time-kill analysis demonstrated a mean bacteriostatic effect of genipin against staphylococci at 1 × MBC after 120 minutes, and a mean bactericidal effect after 120 minutes at 2.5 × MBC and after 60 minutes at 5 × MBC. No antibacterial effect was measured for P. aeruginosa within the tested timeframe and genipin concentrations. CONCLUSIONS: Genipin exhibited promising antibacterial activity against all tested isolates, including MRSP. We suggest that genipin acts as a concentration-dependent antimicrobial agent, demonstrating bactericidal activity at higher concentrations against staphylococci. P. aeruginosa appeared less susceptible to the short-term effects of genipin. Further investigation is warranted to elucidate genipin's full antimicrobial potential and clinical performance.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Slenter IJM, Smit AAG, Schipper BW, et al. The In Vitro Antibacterial Effects of Genipin Against Pathogens Commonly Associated With Infected Ulcerative Keratitis: A Canine Preliminary Study. Invest Ophthalmol Vis Sci. 2026. PMID: 41800841. doi:10.1167/iovs.67.3.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。